Galderma Group AG
Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma
- Conditions
- First Posted Date
- 2007-05-04
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 70
- Registration Number
- NCT00469183
- Locations
- 🇺🇸
Vitiligo and Pigmentation Institute of Southern California, Los Angeles, California, United States
🇺🇸University of Texas Southwestern Medical Center of Dallas, Dallas, Texas, United States
Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne
- Conditions
- Interventions
- First Posted Date
- 2007-05-04
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 302
- Registration Number
- NCT00469755
- Locations
- 🇺🇸
Therapeutics Clinical Research, San Diego, California, United States
🇺🇸Henry Ford Medical Center-Dept. of Dermatology, Detroit, Michigan, United States
🇺🇸State University of New York Downstate Medical Center-Dept. of Dermatology, Brooklyn, New York, United States
Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjects
- First Posted Date
- 2007-03-12
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 452
- Registration Number
- NCT00446043
- Locations
- 🇺🇸
Phoebe Rich, MD, Portland, Oregon, United States
Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris
- Conditions
- First Posted Date
- 2007-02-28
- Last Posted Date
- 2021-02-17
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 272
- Registration Number
- NCT00441415
- Locations
- 🇺🇸
Paul YAMAUCHI, Santa Monica, California, United States
🇺🇸Steven E. KEMPERS, Fridley, Minnesota, United States
🇺🇸Dr Alicia BUCKO, Albuquerque, New Mexico, United States
Subject Preference for Scalp Psoriasis Treatment
- First Posted Date
- 2007-02-22
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 219
- Registration Number
- NCT00438399
- Locations
- 🇮🇹
Clinica Dermatologica Azienda Ospedaliera Policlinico di Modena, Modena, Italy
Comparison of Metvix Photodynamic Therapy (PDT) With Its Vehicle in the Treatment of Photoaged Skin
- Conditions
- Interventions
- First Posted Date
- 2007-02-21
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 32
- Registration Number
- NCT00437320
- Locations
- 🇪🇸
Policlinico Ruber, Madrid, Spain
🇬🇧Whittington Hospital, London, United Kingdom
🇬🇧University of Manchester-Hope Hospital, Manchester, United Kingdom
Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 2488
- Registration Number
- NCT00437216
- Locations
- 🇺🇸
DHC Dimensional HealthCare, Inc. (Clinical Research Organization), Cedar Knolls, New Jersey, United States
Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 26
- Registration Number
- NCT00436527
- Locations
- 🇺🇸
Colorado Springs Research Center, Colorado Springs, Colorado, United States
A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam
- Conditions
- Interventions
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 78
- Registration Number
- NCT00436540
- Locations
- 🇺🇸
Central Dermatology, PC, Saint Louis, Missouri, United States
🇺🇸Solano Clinical Research, Vallejo, California, United States
Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 122
- Registration Number
- NCT00437255
- Locations
- 🇺🇸
Minnesota Clinical Study Center, Fridley, Minnesota, United States
🇺🇸J & S Studies, Inc., Bryan, Texas, United States
🇺🇸Baylor Research Institute, Dallas, Texas, United States